Professor M. Schemann: Lehrstuhl für Humanbiologie, Technische Universität München, Liesel-Beckmann-Straße 4, 85350 Freising-Weihenstephan, Germany.
J Physiol. 2013 Oct 15;591(20):5125-39. doi: 10.1113/jphysiol.2013.262733. Epub 2013 Aug 12.
Colonic transit and mucosal integrity are believed to be impaired in obesity. However, a comprehensive assessment of altered colonic functions, inflammatory changes and neuronal signalling of obese animals is missing. In mice, we studied the impact of diet-induced obesity (DIO) on: (i) in vivo colonic transit; (ii) signalling in the myenteric plexus by recording responses to nicotine and 2-methyl-5-hydroxytryptamine (2-methyl-5-HT), together with the expression of tryptophan hydroxylase (TPH) 1 and 2, serotonin reuptake transporter, choline acetyltransferase and the paired box gene 4; and (iii) expression of proinflammatory cytokines, epithelial permeability and density of macrophages, mast cells and enterochromaffin cells. Compared with controls, colon transit and neuronal sensitivity to nicotine and 2-methyl-5-HT were enhanced in DIO mice fed for 12 weeks. This was associated with increased tissue acetylcholine and 5-hydroxytryptamine (5-HT) content, and increased expression of TPH1 and TPH2. In DIO mice, upregulation of proinflammatory cytokines was found in fat tissue, but not in the gut wall. Accordingly, mucosal permeability or integrity was unaltered without signs of immune cell infiltration in the gut wall. Body weight showed positive correlations with adipocyte markers, tissue levels of 5-HT and acetylcholine, and the degree of neuronal sensitization. DIO mice fed for 4 weeks showed no neuronal sensitization, had no signs of gut wall inflammation and showed a smaller increase in leptin, interleukin-6 and monocyte chemoattractant protein 1 expression in fat tissue. DIO is associated with faster colonic transit and impacts on acetylcholine and 5-HT metabolism with enhanced responsiveness of enteric neurones to both mediators after 12 weeks of feeding. Our study demonstrates neuronal plasticity in DIO prior to the development of a pathological histology or abnormal mucosal functions. This questions the common assumption that increased mucosal inflammation and permeability initiate functional disorders in obesity.
人们认为肥胖会损害结肠转运和黏膜完整性。然而,目前缺乏对肥胖动物结肠功能改变、炎症变化和神经元信号的全面评估。在小鼠中,我们研究了饮食诱导肥胖(DIO)对以下方面的影响:(i)体内结肠转运;(ii)通过记录对尼古丁和 2-甲基-5-羟色胺(2-甲基-5-HT)的反应,评估肌间神经丛中的信号转导,同时评估色氨酸羟化酶(TPH)1 和 2、5-羟色胺再摄取转运体、胆碱乙酰转移酶和配对盒基因 4 的表达;(iii)促炎细胞因子的表达、上皮通透性以及巨噬细胞、肥大细胞和肠嗜铬细胞的密度。与对照组相比,12 周喂养的 DIO 小鼠的结肠转运和神经元对尼古丁和 2-甲基-5-HT 的敏感性增强。这与组织乙酰胆碱和 5-羟色胺(5-HT)含量增加以及 TPH1 和 TPH2 表达增加有关。在 DIO 小鼠中,脂肪组织中促炎细胞因子的表达上调,但在肠壁中没有。因此,肠壁中没有发现黏膜通透性或完整性改变,也没有免疫细胞浸润的迹象。体重与脂肪细胞标志物、组织 5-HT 和乙酰胆碱水平以及神经元敏感性增加呈正相关。喂养 4 周的 DIO 小鼠没有神经元敏感性增加的迹象,肠壁没有炎症迹象,脂肪组织中瘦素、白细胞介素-6 和单核细胞趋化蛋白 1 的表达增加幅度较小。DIO 与更快的结肠转运有关,并在 12 周喂养后影响乙酰胆碱和 5-HT 代谢,使肠神经元对这两种介质的反应增强。我们的研究表明,在发生病理性组织学或异常黏膜功能之前,DIO 与神经元可塑性有关。这对“增加的黏膜炎症和通透性会引发肥胖症中的功能障碍”这一常见假设提出了质疑。